These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9853160)

  • 1. Nasolacrimal polyurethane stent: complications with CT correlation.
    Pinto IT; Paul L; Grande C
    Cardiovasc Intervent Radiol; 1998; 21(6):450-3. PubMed ID: 9853160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of nasolacrimal duct obstruction in adults with polyurethane stent.
    Yazici B; Yazici Z; Parlak M
    Am J Ophthalmol; 2001 Jan; 131(1):37-43. PubMed ID: 11162977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of complete and partial obstruction of the nasolacrimal system with polyurethane stents: initial experience.
    Pulido-Duque JM; Reyes R; Carreira JM; Vega F; Górriz E; Pardo MD; Perez F; Maynar M
    Cardiovasc Intervent Radiol; 1998; 21(1):41-4. PubMed ID: 9473545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of the polyurethane stent without fluoroscopic guidance in the treatment of nasolacrimal duct obstruction.
    Lee JS; Jung G; Oum BS; Lee SH; Roh HJ
    Ophthalmology; 2000 Sep; 107(9):1666-70. PubMed ID: 10964826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasolacrimal polyurethane stent placement: preliminary results.
    Perena MF; Castillo J; Medrano J; De Gregorio MA; Loras E; Cristobal JA
    Eur J Ophthalmol; 2001; 11(1):25-30. PubMed ID: 11284481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsurgical placement of a nasolacrimal polyurethane stent: long-term effectiveness.
    Song HY; Jin YH; Kim JH; Suh SW; Yoon HK; Kang SG; Sung KB
    Radiology; 1996 Sep; 200(3):759-63. PubMed ID: 8756928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of complete obstruction of the nasolacrimal system by temporary placement of nasolacrimal polyurethane stents: preliminary results.
    Paúl L; Pinto I; Vicente JM
    Clin Radiol; 2003 Nov; 58(11):876-82. PubMed ID: 14581012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasolacrimal polyurethane stent placement for epiphora: technical long-term results.
    Pabón IP; Díaz LP; Grande C; de la Cal López MA
    J Vasc Interv Radiol; 2001 Jan; 12(1):67-71. PubMed ID: 11200356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of nasolacrimal duct obstruction with polyurethane stent placement: long-term results.
    Yazici Z; Yazici B; Parlak M; Tuncel E; Ertürk H
    AJR Am J Roentgenol; 2002 Aug; 179(2):491-4. PubMed ID: 12130461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasolacrimal stents for the treatment of epiphora: technical problems and long-term results.
    Pinilla I; Fernández-Prieto AF; Asencio M; Arbizu A; Peláez N; Frutos R
    Orbit; 2006 Jun; 25(2):75-81. PubMed ID: 16754213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of polyurethane stent implantation for the treatment of complete obstruction of the nasolacrimal system: 8-month follow-up and complications].
    Anders N; Hoffmann KT; Hosten N; Walkow T; Felix R; Hartmann C
    Ophthalmologe; 1999 Oct; 96(10):658-62. PubMed ID: 10552159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The polyurethane nasolacrimal duct stent for lower tear duct obstruction: long-term success rate and complications.
    Schaudig U; Maas R
    Graefes Arch Clin Exp Ophthalmol; 2000 Sep; 238(9):733-7. PubMed ID: 11045340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of epiphora with nasolacrimal stents: results of long-term follow-up in a multicenter prospective study.
    Lanciego C; Toledano N; De Miguel S; Perea M; Padilla M; Rodriguez-Merlo R; Dávila J; Ibarburen C; Cano C; García IR; García LG
    J Vasc Interv Radiol; 2003 Nov; 14(11):1417-25. PubMed ID: 14605107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasolacrimal stents in the management of epiphora: medium-term results of a multicenter prospective study.
    Lanciego C; De Miguel S; Perea M; Cano C; García IR; Dávila J; Ibarburen C; Toledano N; Rodriguez-Merlo R; García LG
    J Vasc Interv Radiol; 2001 Jun; 12(6):701-10. PubMed ID: 11389221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of patients with nasolacrimal polyurethane stent implantation: do they keep tearing?
    Oztürk S; Konuk O; Ilgit ET; Unal M; Erdem O
    Ophthalmic Plast Reconstr Surg; 2004 Mar; 20(2):130-5. PubMed ID: 15083082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic findings after nasolacrimal polyurethane stent implantations.
    Lee JH; Kang MS; Yang JW
    Korean J Ophthalmol; 2005 Dec; 19(4):252-7. PubMed ID: 16491813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy.
    Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D
    JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nasolacrimal stent implantation: report of a case].
    Lunardelli P; Aoki L; Jervásio AC; Zagui RM; Matayoshi S
    Arq Bras Oftalmol; 2008; 71(1):110-4. PubMed ID: 18408851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacrimal system obstruction treated with lacrimal polyurethane stents: outcome of removal of occluded stents.
    Song HY; Lee DH; Ahn H; Kim JH; Kang SG; Yoon HK; Sung KB
    Radiology; 1998 Sep; 208(3):689-94. PubMed ID: 9722847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of preoperative digital subtraction dacryocystography for nasolacrimal stent].
    Xiao MY; Huang PN; Zhang ZS
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):416-8. PubMed ID: 12206023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.